Impact Biomedicines Report issue

For profit Phase 1
Founded: San Diego CA United States (2016)
Status: Acquired by Celgene (2018) → now Bristol-Myers Squibb (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BioMedicines

Active Ingredients

Drugs in Phase 1 Trials (2)

aldesleukin (Proleukin) (1 trial)

biomed 101 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Renal Cell (Phase 1)

Kidney Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2